Cargando…

The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder

Substance use disorder is characterized by repeated use of a substance, leading to clinically significant distress, making it a serious public health concern. The endocannabinoid system plays an important role in common neurobiological processes underlying substance use disorder, in particular by me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chye, Yann, Christensen, Erynn, Solowij, Nadia, Yücel, Murat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390812/ https://www.ncbi.nlm.nih.gov/pubmed/30837904 http://dx.doi.org/10.3389/fpsyt.2019.00063

Ejemplares similares

Prolonged Cannabidiol Treatment Effects on Hippocampal Subfield Volumes in Current Cannabis Users
por: Beale, Camilla, et al.
Publicado: (2018)

Investigating the Residual Effects of Chronic Cannabis Use and Abstinence on Verbal and Visuospatial Learning
por: Lorenzetti, Valentina, et al.
Publicado: (2021)

Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia
por: Desfossés, Joëlle, et al.
Publicado: (2012)

Clinical Trials of Cannabidiol for Substance Use Disorders: Outcome Measures, Surrogate Endpoints, and Biomarkers
por: Morel, Alix, et al.
Publicado: (2021)

Young Adults With Higher Motives and Expectancies of Regular Cannabis Use Show Poorer Psychosocial Functioning
por: Amiet, Danielle, et al.
Publicado: (2020)

Cannabidiol and Neurodevelopmental Disorders in Children
por: Kwan Cheung, Keith A., et al.
Publicado: (2021)

Biomarkers of the Endocannabinoid System in Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2022)

Endocannabinoids and Precision Medicine for Mood Disorders and Suicide
por: Pinna, Graziano
Publicado: (2021)

Endocannabinoid System Unlocks the Puzzle of Autism Treatment via Microglia
por: Su, Tangfeng, et al.
Publicado: (2021)

A “Good” Smoke? The Off-Label Use of Cannabidiol to Reduce Cannabis Use
por: Fortin, Davide, et al.
Publicado: (2022)

Efficiency of Inhaled Cannabidiol in Cannabis Use Disorder: The Pilot Study Cannavap
por: Cleirec, Grégoire, et al.
Publicado: (2022)

Enhancing Endocannabinoid Control of Stress with Cannabidiol
por: Henson, Jeremy D., et al.
Publicado: (2021)

Endocannabinoid System Components as Potential Biomarkers in Psychiatry
por: Navarrete, Francisco, et al.
Publicado: (2020)

Modulation of the Endocannabinoid System: Vulnerability Factor and New Treatment Target for Stimulant Addiction
por: Olière, Stéphanie, et al.
Publicado: (2013)

Endocannabinoid Gene × Gene Interaction Association to Alcohol Use Disorder in Two Adolescent Cohorts
por: Elkrief, Laurent, et al.
Publicado: (2021)

Cannabidiol Cigarettes as Adjunctive Treatment for Psychotic Disorders – A Randomized, Open-Label Pilot-Study
por: Köck, Patrick, et al.
Publicado: (2021)

The Endocannabinoid System and Cannabidiol: Past, Present, and Prospective for Cardiovascular Diseases
por: Rabino, Martina, et al.
Publicado: (2021)

The endocannabinoid system, cannabis, and cannabidiol: Implications in urology and men's health
por: Capodice, Jillian L., et al.
Publicado: (2021)

Commonalities for comorbidity: Overlapping features of the endocannabinoid system in depression and epilepsy
por: Epps, S. Alisha
Publicado: (2022)

Editorial: Application of New Technologies in the Treatment of Substance Use Disorders
por: Zhang, Kai
Publicado: (2021)

Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry
por: De Gregorio, Danilo, et al.
Publicado: (2021)

Use of Gabapentin in the Treatment of Substance Use and Psychiatric Disorders: A Systematic Review
por: Ahmed, Saeed, et al.
Publicado: (2019)

Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic Review
por: Jones, Jennifer L., et al.
Publicado: (2018)

Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2021)

Circadian Rhythmic Characteristics in Men With Substance Use Disorder Under Treatment. Influence of Age of Onset of Substance Use and Duration of Abstinence
por: Capella, Maria del Mar, et al.
Publicado: (2018)

The Neurobiology of Cannabis Use Disorders: A Call for Evidence
por: Lorenzetti, Valentina, et al.
Publicado: (2016)

A History of Childhood Maltreatment Has Substance- and Sex-Specific Effects on Craving During Treatment for Substance Use Disorders
por: Gerhardt, Sarah, et al.
Publicado: (2022)

FAAH and CNR1 Polymorphisms in the Endocannabinoid System and Alcohol-Related Sleep Quality
por: Soundararajan, Soundarya, et al.
Publicado: (2021)

Fluctuating Disinhibition: Implications for the Understanding and Treatment of Alcohol and Other Substance Use Disorders
por: Jones, Andrew, et al.
Publicado: (2013)

Attachment and Substance Use Disorders—Theoretical Models, Empirical Evidence, and Implications for Treatment
por: Schindler, Andreas
Publicado: (2019)

Methylphenidate as a treatment option for substance use disorder: a transdiagnostic perspective
por: van Ruitenbeek, Peter, et al.
Publicado: (2023)

Traumatic Events and Substance Use Disorders in Adolescents
por: Basedow, Lukas A., et al.
Publicado: (2020)

From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?
por: Bitencourt, Rafael M., et al.
Publicado: (2021)

Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment
por: Palumbo, Joseph M., et al.
Publicado: (2023)

The Influence of Trait Compulsivity and Impulsivity on Addictive and Compulsive Behaviors During COVID-19
por: Albertella, Lucy, et al.
Publicado: (2021)

The Endocannabinoid System across Postnatal Development in Transmembrane Domain Neuregulin 1 Mutant Mice
por: Chesworth, Rose, et al.
Publicado: (2018)

Attachment and Therapeutic Alliance in Substance Use Disorders: Initial Findings for Treatment in the Therapeutic Community
por: Rübig, Leonie L., et al.
Publicado: (2021)

The Puzzling Unidimensionality of the DSM Substance Use Disorders: Commentary
por: Martin, Christopher Stephen
Publicado: (2013)

Phenibut Addiction in a Patient with Substance Use Disorder
por: Zheng, Kan Hong, et al.
Publicado: (2019)

Editorial: Parents With Mental and/or Substance Use Disorders and Their Children
por: Nicholson, Joanne, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_02m9k4k7ft7u2vn53n2fk90ugb